Antibiotic prophylaxis and therapy in burns.
Gillett
A P
AP
D000287:Administration, Topical; D000900:Anti-Bacterial Agents / Q000378:metabolism / Q000627:therapeutic use; D002056:Burns / Q000150:complications / Q000276:immunology / Q000382:microbiology*; D002710:Chlorhexidine / Q000627:therapeutic use; D005839:Gentamicins / Q000627:therapeutic use; D006801:Humans; D007700:Kinetics; D008272:Mafenide / Q000627:therapeutic use; D011113:Polymyxins / Q000627:therapeutic use; D011206:Povidone-Iodine / Q000627:therapeutic use; D011552:Pseudomonas Infections / Q000517:prevention & control; D012835:Silver Nitrate / Q000627:therapeutic use; D012837:Silver Sulfadiazine / Q000627:therapeutic use; D013203:Staphylococcal Infections / Q000517:prevention & control; D013290:Streptococcal Infections / Q000517:prevention & control; D014946:Wound Infection / Q000209:etiology / Q000517:prevention & control*
D000900:Anti-Bacterial Agents; D005839:Gentamicins; D011113:Polymyxins; D008272:Mafenide; D011206:Povidone-Iodine; D012835:Silver Nitrate; D002710:Chlorhexidine; D012837:Silver Sulfadiazine